In experimental studies, ketogenic interventions successfully reduced disease progression in polycystic kidney disease animal models, possibly by lowering glucose availability in renal tubular cells and by reducing mammalian target of rapamycin (mTOR) signaling [6, 7]. The gene discussed is MTOR; the disease is polycystic kidney disease.